Compare JMIA & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JMIA | STAA |
|---|---|---|
| Founded | 2012 | 1982 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 862.0M | 867.9M |
| IPO Year | 2018 | 1995 |
| Metric | JMIA | STAA |
|---|---|---|
| Price | $6.93 | $32.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $16.75 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 2.7M | 874.7K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | $22.18 | $30.82 |
| Revenue Next Year | $23.26 | $8.41 |
| P/E Ratio | ★ N/A | $328.05 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.02 | $15.59 |
| 52 Week High | $14.72 | $35.87 |
| Indicator | JMIA | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 45.23 | 77.35 |
| Support Level | $6.70 | $23.75 |
| Resistance Level | $9.49 | $35.87 |
| Average True Range (ATR) | 0.55 | 1.50 |
| MACD | -0.05 | 0.25 |
| Stochastic Oscillator | 12.48 | 66.12 |
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace that connects sellers with consumers. The logistics services of the company enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. The company generates revenue from first-party sales, third-party sales, marketing and advertising, and the provision of other services. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.